SABCS 2024 Insights: Impact of Prior Treatment, ESR1 Mutations, and PI3K Pathway on Elacestrant Outcomes in HR+/HER2- Advanced Breast Cancer | VuMedi

Find latest Breast Cancer videos · 1000+ videos

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

SABCS 2024 Insights: Impact of Prior Treatment, ESR1 Mutations, and PI3K Pathway on Elacestrant Outcomes in HR+/HER2- Advanced Breast Cancer

By 2024 SABCS Annual Meeting Insights Hub FEATURING Maxwell Lloyd

By 2024 SABCS Annual Meeting Insights Hub FEATURING Maxwell Lloyd

132 views

December 17, 2024

Comments 0

Login to view comments. Click here to Login